SELLAS Life Sciences Group, Inc. Preferred Stock, Shares Issued
SELLAS Life Sciences Group, Inc. (SLS) had Preferred Stock, Shares Issued of 0 shares as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2024-11-13
- 2024-09-30: Preferred Stock, Shares Issued 0.00 shares.
- 2024-06-30: Preferred Stock, Shares Issued 0.00 shares.
- 2024-03-31: Preferred Stock, Shares Issued 0.00 shares.
- 2023-12-31: Preferred Stock, Shares Issued 0.00 shares.
| Period end | Preferred Stock, Shares Issued |
|---|---|
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 0.00 shares 10-Q · filed 2024-11-13 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-16 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 0.00 shares 10-Q · filed 2021-11-12 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-13 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-14 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-23 |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-14 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-13 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-14 |
| 2018-06-30 | 7.80K shares 10-Q · filed 2018-08-14 |
| 2018-03-31 | 5.99K shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-22 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-04-13 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-03-15 |
| 2014-12-31 | 0.00 shares 10-K/A · filed 2016-04-15 |
| 2013-12-31 | 0.00 shares 8-K · filed 2015-12-04 |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-17 |
| 2011-06-30 | 0.00 shares 10-Q · filed 2011-08-15 |
| 2010-12-31 | 0.00 shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |